BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 3371576)

  • 1. Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion.
    Jensen T; Stender S; Deckert T
    Diabetologia; 1988 Mar; 31(3):142-5. PubMed ID: 3371576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple lipoprotein abnormalities in type I diabetic patients with renal disease.
    Groop PH; Elliott T; Ekstrand A; Franssila-Kallunki A; Friedman R; Viberti GC; Taskinen MR
    Diabetes; 1996 Jul; 45(7):974-9. PubMed ID: 8666151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased urinary loss of high density lipoproteins in albuminuric insulin-dependent diabetic patients.
    Haaber AB; Deckert M; Stender S; Jensen T
    Scand J Clin Lab Invest; 1993 Apr; 53(2):191-6. PubMed ID: 8469918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cholesteryl ester transfer protein and its relationship to plasma lipoproteins and apolipoprotein A-I-containing lipoproteins in IDDM patients with microalbuminuria and clinical nephropathy.
    Kahri J; Groop PH; Elliott T; Viberti G; Taskinen MR
    Diabetes Care; 1994 May; 17(5):412-9. PubMed ID: 8062608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between lipoprotein profile and urinary albumin excretion in type II diabetic patients with stable metabolic control.
    Reverter JL; Sentí M; Rubiés-Prat J; Lucas A; Salinas I; Pizarro E; Pedro-Botet J; Romero R; Sanmartí A
    Diabetes Care; 1994 Mar; 17(3):189-94. PubMed ID: 8174446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Willebrand factor and early diabetic retinopathy: no evidence for a relationship in patients with type 1 (insulin-dependent) diabetes mellitus and normal urinary albumin excretion.
    Stehouwer CD; Zellenrath P; Polak BC; Baarsma GS; Nauta JJ; Donker AJ; den Ottolander GJ
    Diabetologia; 1992 Jun; 35(6):555-9. PubMed ID: 1612229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triglyceride-glucose index: A surrogate marker of homeostasis model assessment of insulin resistance to predict diabetic nephropathy.
    Khan S; Qayyum S; Khan MNA
    J Pak Med Assoc; 2024 May; 74(5):862-867. PubMed ID: 38783431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria.
    Jones SL; Close CF; Mattock MB; Jarrett RJ; Keen H; Viberti GC
    BMJ; 1989 Feb; 298(6672):487-90. PubMed ID: 2495077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy.
    Yokoyama H; Jensen JS; Jensen T; Deckert T
    J Intern Med; 1995 May; 237(5):519-23. PubMed ID: 7738493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipids, lipoproteins, antioxidants and glomerular and tubular dysfunction in type 1 diabetes.
    O'Brien SF; Watts GF; Powrie JK; Shaw KM; Miller NJ
    Diabetes Res Clin Pract; 1996 Apr; 32(1-2):81-90. PubMed ID: 8803485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study.
    Greaves M; Malia RG; Goodfellow K; Mattock M; Stevens LK; Stephenson JM; Fuller JH
    Diabetologia; 1997 Jun; 40(6):698-705. PubMed ID: 9222650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of early diabetic nephropathy on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition.
    Winocour PH; Durrington PN; Bhatnagar D; Ishola M; Mackness M; Arrol S
    Atherosclerosis; 1991 Jul; 89(1):49-57. PubMed ID: 1772471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria.
    Kapelrud H; Bangstad HJ; Dahl-Jørgensen K; Berg K; Hanssen KF
    BMJ; 1991 Sep; 303(6804):675-8. PubMed ID: 1833011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study.
    Coonrod BA; Ellis D; Becker DJ; Bunker CH; Kelsey SF; Lloyd CE; Drash AL; Kuller LH; Orchard TJ
    Diabetes Care; 1993 Oct; 16(10):1376-83. PubMed ID: 8269796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipids and lipoproteins in insulin-dependent diabetic patients with persistent microalbuminuria.
    Watts GF; Naumova R; Slavin BM; Morris RW; Houlston R; Kubal C; Shaw KM
    Diabet Med; 1989; 6(1):25-30. PubMed ID: 2522370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients.
    Manzato E; Zambon A; Zambon S; Nosadini R; Doria A; Marin R; Crepaldi G
    Acta Diabetol; 1993; 30(1):11-6. PubMed ID: 8329725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein (a) and microvascular disease in type 1 (insulin-dependent) diabetes.
    Winocour PH; Bhatnagar D; Ishola M; Arrol S; Durrington PN
    Diabet Med; 1991 Dec; 8(10):922-7. PubMed ID: 1838043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy.
    Hommel E; Andersen P; Gall MA; Nielsen F; Jensen B; Rossing P; Dyerberg J; Parving HH
    Diabetologia; 1992 May; 35(5):447-51. PubMed ID: 1521727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.